Log in to save to my catalogue

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine...

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9881745

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia

About this item

Full title

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia

Publisher

Netherlands: Elsevier Limited

Journal title

Vaccine, 2022-09, Vol.40 (41), p.5912-5923

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Limited

More information

Scope and Contents

Contents

Highlights•This correlates analysis integrated host immune response & pathogen sequence data. •The nAb correlate of risk depends on dengue sequence in baseline seropositive participants. •Dependency of correlates on sequence-distance stronger in the vaccine (vs placebo) arm. •Infection- vs vaccine-induced nAbs may affect dengue risk differently. •n...

Alternative Titles

Full title

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9881745

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9881745

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2022.08.055

How to access this item